The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country's largest and second-deadliest on record with over 7,000 cases and 3,400 deaths as of early September 2026, drives trader sentiment through rapid geographic spread across seven provinces amid conflict, displacement, and uneven contact tracing. Imported cases reached Uganda before its declaration of Ebola-free status, while modeling highlights elevated spillover risk to South Sudan via travel routes and weak infrastructure, with lower probabilities for neighbors like Rwanda or Burundi. Persistent transmission despite DRC claims of control, plus one noted case in France, underscores how insecurity and late detection fuel uncertainty around additional 2026 confirmations before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$38,659 Wol.
Dec 31, 2026
South Sudan
68%
Rwanda
23%
Burundi
46%
United States
19%
Canada
23%
Kenya
23%
India
46%
Republic of the Congo
23%
Nigeria
47%
Ethiopia
52%
Somalia
36%
China
13%
$38,659 Wol.
South Sudan
$4,363 Wol.
68%
Rwanda
$2,149 Wol.
23%
Burundi
$202 Wol.
46%
United States
$10,507 Wol.
19%
Canada
$2,307 Wol.
23%
Kenya
$235 Wol.
23%
India
$737 Wol.
46%
Republic of the Congo
$12,400 Wol.
23%
Nigeria
$25 Wol.
47%
Ethiopia
$107 Wol.
52%
Somalia
$129 Wol.
36%
China
$3,543 Wol.
13%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country's largest and second-deadliest on record with over 7,000 cases and 3,400 deaths as of early September 2026, drives trader sentiment through rapid geographic spread across seven provinces amid conflict, displacement, and uneven contact tracing. Imported cases reached Uganda before its declaration of Ebola-free status, while modeling highlights elevated spillover risk to South Sudan via travel routes and weak infrastructure, with lower probabilities for neighbors like Rwanda or Burundi. Persistent transmission despite DRC claims of control, plus one noted case in France, underscores how insecurity and late detection fuel uncertainty around additional 2026 confirmations before year-end resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Rynek otwarty: May 22, 2026, 12:35 PM ET
Wolumen
$38,659Data zakończenia
Jan 1, 2027Rynek otwarty
May 22, 2026, 12:35 PM ETRozstrzygający
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country's largest and second-deadliest on record with over 7,000 cases and 3,400 deaths as of early September 2026, drives trader sentiment through rapid geographic spread across seven provinces amid conflict, displacement, and uneven contact tracing. Imported cases reached Uganda before its declaration of Ebola-free status, while modeling highlights elevated spillover risk to South Sudan via travel routes and weak infrastructure, with lower probabilities for neighbors like Rwanda or Burundi. Persistent transmission despite DRC claims of control, plus one noted case in France, underscores how insecurity and late detection fuel uncertainty around additional 2026 confirmations before year-end resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Wolumen
$38,659Data zakończenia
Jan 1, 2027Rynek otwarty
May 22, 2026, 12:35 PM ETRozstrzygający
0x65070BE91...The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo, now the country's largest and second-deadliest on record with over 7,000 cases and 3,400 deaths as of early September 2026, drives trader sentiment through rapid geographic spread across seven provinces amid conflict, displacement, and uneven contact tracing. Imported cases reached Uganda before its declaration of Ebola-free status, while modeling highlights elevated spillover risk to South Sudan via travel routes and weak infrastructure, with lower probabilities for neighbors like Rwanda or Burundi. Persistent transmission despite DRC claims of control, plus one noted case in France, underscores how insecurity and late detection fuel uncertainty around additional 2026 confirmations before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania